 Connection
Matthew Keller to Mutation, Missense
This is a "connection" page, showing publications Matthew Keller has written about Mutation, Missense.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.182 |
|
|
|
-
Stivala S, Codilupi T, Brkic S, Baerenwaldt A, Ghosh N, Hao-Shen H, Dirnhofer S, Dettmer MS, Simillion C, Kaufmann BA, Chiu S, Keller M, Kleppe M, Hilpert M, Buser AS, Passweg JR, Radimerski T, Skoda RC, Levine RL, Meyer SC. Targeting compensatory MEK/ERK activation increases JAK inhibitor efficacy in myeloproliferative neoplasms. J Clin Invest. 2019 03 04; 129(4):1596-1611.
Score: 0.132
-
Kellermayer R, Keller M, Ratajczak P, Richardson E, Harangi F, Mérei E, Melegh B, Kosztolányi G, Richard G. Bigenic connexin mutations in a patient with hidrotic ectodermal dysplasia. Eur J Dermatol. 2005 Mar-Apr; 15(2):75-9.
Score: 0.050
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|